What is Opioid Use Disorder?
Opioid use disorder (OUD) is a chronic brain disease characterized by compulsive opioid use, unsuccessful efforts to reduce or control use, continued use despite causing social problems or failure to fulfill major obligations at work/school/home, and use resulting in clinically significant impairment or distress 1, 2.
Core Diagnostic Features
OUD represents a problematic pattern of opioid use that goes beyond normal therapeutic use. The DSM-5 criteria identify OUD when patients exhibit behaviors including 1, 2:
- Pronounced craving for the drug
- Obsessive preoccupation with obtaining opioids
- Inability to refrain from using despite wanting to stop
- Escalation of drug taking beyond prescribed amounts
- Social consequences including failure to meet work, school, or home responsibilities
- Continued use despite physical or psychological problems caused by opioids
Critical Distinction: OUD vs. Normal Physiologic Responses
This is the most important clinical pitfall: OUD is fundamentally different from tolerance and physical dependence, which are normal physiologic adaptations to chronic opioid exposure 1, 2.
- Tolerance (diminished response requiring higher doses) can occur with appropriate medical use
- Physical dependence (withdrawal symptoms when stopping) occurs in most patients on chronic opioids
- Neither tolerance nor physical dependence alone constitutes OUD
Special Considerations for Chronic Pain Patients
In your 60-year-old patient taking 20 mg oxycodone daily for chronic pain, diagnosing OUD requires careful evaluation 3, 4:
Red flags that suggest OUD rather than undertreated pain:
- Taking opioids to "get high" or cope with negative emotions (not just for pain relief)
- Using opioids in ways other than prescribed (crushing, snorting, injecting)
- Obtaining opioids from multiple sources or "doctor shopping"
- Continued escalation despite adequate pain control
- Neglecting major life responsibilities due to opioid use
Common diagnostic errors to avoid 4:
- Misinterpreting desire for pain relief as drug-seeking behavior
- Confusing requests for dose increases due to inadequate analgesia with compulsive use
- Failing to distinguish therapeutic intent from non-therapeutic motives
Research shows that without in-depth questioning, there is substantial risk of false-positive OUD diagnosis in pain patients, particularly when DSM-5 criteria are applied superficially 4.
Prevalence and Risk Factors
Among patients on long-term opioid therapy for chronic pain, OUD prevalence ranges from 3% to 26% in primary care settings 1.
Highest risk patients include those with 1, 2:
- History of substance use disorder (any substance)
- Current or past psychiatric disorders (depression, anxiety)
- Family history of addiction or psychiatric illness
- Younger age (adolescents and young adults have enhanced neuroplasticity making them condition to drugs more rapidly)
- Use of psychotropic medications
- Higher opioid doses and longer treatment duration
Neurobiological Basis
OUD involves disruption of brain reward circuits 2:
- Opioids trigger dopamine release in the nucleus accumbens (reward center)
- Repeated exposure creates learned associations between drug use and pleasure/pain relief
- Over time, this conditioning disrupts prefrontal cortical function needed for self-control
- These brain changes persist years after discontinuation, making OUD a chronic relapsing condition
Clinical Implications
For your patient specifically: The 20 mg daily oxycodone dose is relatively modest. If the patient is taking medication exactly as prescribed solely for pain relief, shows no drug-seeking behaviors, maintains normal function, and has no history of substance abuse, they likely do NOT have OUD—even if they experience withdrawal when missing doses (which is normal physical dependence) 1, 3.
However, the CDC guidelines emphasize that all patients on chronic opioids require regular reassessment for signs of OUD, particularly when considering prescription renewal 2.